Jobs / United States / Glaxosmithkline LLC
Director, Real World Data Platform and Portfolio Lead
Glaxosmithkline LLC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Product Director, Platform API” (Information Technology Project Managers) in TX: $149k–$149k, median $149k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage, UK. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge, UK in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029. Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together. Summary You will be accountable for the strategic execution and coordination of our internal and external RWD platform partnerships to impact R&D and CPO activities, delivering insights, models and evidence and ensuring maximum scientific value demonstration from use of RWD as a key input into decision making, pipeline progress and portfolio growth. As the external data landscapes evolves globally, increasing competitive advantage is obtained by thoughtful data partnerships that align with GSK’s translational, development and commercialisation goals. GSK facilitates a global RWD platform of partners, systems and collaborators which collectively enables a wide availability of data which acts as critical enabler for insight, models and evidence generation. Reporting to the Executive Director and Head, RWD Strategy and Partnerships, this is a critical role of coordinating our RWD strategy and execution across our wide network of internal and external stakeholders. This role will be tasked with ownership and operational execution of RWD investment and key capability partnership aligned with GSK’s wider vision The role will be directly accountable for our core data partnerships which sit above one particular therapy area representing health systems more widely and across key regions where RWD is being made available. Where relevant this role will support integration and elevation of these datasets internally as well as providing operational leadership to our above TA portfolio. The successful candidate must demonstrate exceptional data strategy and operations skills and work with key functions in Translational and Development Sciences and Medical Affairs to ensure excellence in data acquisition and access whilst maximising the overall availability of external data. Core Accountabilities • Lead and execute above disease area/tumour type RWD partnerships, build partnerships built around expanding RWD capabilities and identifying new opportunities to access population level health datasets. Where relevant partner with Translational Sciences on RWD partnerships linked to -omics, biobanks and other translational cohorts. • Ensure partnerships offer scale to drive GSK’s RWE ambition and ensure operational execution of evidence generation relating to data access and analysis • Partner in key regions and with regional leaders where population level health data can be leveraged for research, positioning GSK as a leading partner in large observational research and quantitative innovation and enabling • Act as strategic lead for the internal RWD domain for GSK’s data offices, ensuring engineering, programming and AI teams have clear input on wider data strategy plans. • Partner with Real World Data Enginee